A kind of medicine for treating pulmonary infectious disease and application thereof

A technology for pulmonary infection and disease, which is applied to medicines for the treatment of pulmonary infectious diseases and their application fields, and can solve the problems of unclear pharmacological substances and pharmacological effects.
CN103463183BActive Publication Date: 2016-01-20ZHEJIANG ACAD OF MEDICAL SCI
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
ZHEJIANG ACAD OF MEDICAL SCI
Publication Date
2016-01-20

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

A medicine for treating pulmonary infectious diseases and its application belong to the technical field of medicine. The drug contains total flavonoids extracted from Artemisia Sifang or Campanula, neohesperidin dihydrochalcone, naringin dihydrochalcone, 7-methoxywogonin, 6,7-dimethoxy Any one substance or a combination of any two or more substances in baicalein or a pharmaceutically acceptable salt thereof. One aspect of the present invention provides a drug for treating pulmonary infectious diseases, the drug has antiviral effects, inhibits virus-induced lung injury, pulmonary edema, pneumonia, and reduces bronchial mucus secretion and other pharmacological effects. Another aspect of the present invention determines An application of a drug for treating pulmonary infectious diseases, which can be used as a drug for treating acute pneumonia, viral pneumonia, pulmonary edema or bronchitis.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of medicines, in particular to a medicine for treating pulmonary infectious diseases and its application. Background technique

[0002] Lung infection accounts for a large proportion of respiratory diseases or infectious diseases. Due to the limitations of current medical conditions, the chances of iatrogenic and secondary pulmonary infections are becoming more and more serious. Although the application of antibiotics and other antimicrobial drugs has effectively controlled the development of the disease in recent years, with the acceleration of genetic mutation of pathogenic microorganisms and the emergence of drug-resistant bacteria (such as superbugs), as well as the reduction of drug sensitivity of patients, lung The overall morbidity and mortality of internal infection have not been significantly reduced, and the long-term use of antibiotics has more obvious toxic and side effects. Natural medicine ha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More